OPEN END TURBO OPTIONSSCHEIN SHORT - RESMED | Real-time BOERSE MUENCHEN 05:57:17 12/06/2024 pm IST | ||
| 4.62 EUR | +3.59% |
|
| Current month | -9.90% | ||
| 1 month | +5.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 12/24/12 | 4.62 | +3.59% |
| 11/24/11 | 4.46 | -1.76% |
| 10/24/10 | 4.54 | +1.34% |
| 07/24/07 | 4.48 | -0.44% |
| 06/24/06 | 4.5 | +2.97% |
Real-time BOERSE MUENCHEN
Last update June 12, 2024 at 05:57 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Goldman Sachs |
| WKN | GK9LSP |
| ISIN | DE000GK9LSP7 |
| Date issued | 25/08/2022 |
| Strike | 259.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.54 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.2 € |
|---|---|
| Lowest since issue | 2.14 € |
| Spread | 0.02 € |
| Spread % | 0.45% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.2
USD
Average target price
218.7
USD
Spread / Average Target
+4.06%
- Stock Market
- Certificates
- Certificat
